Metraipolis › archive › dc_35d706db8108
Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa — Europe PMC PMID:42602510
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42602510
- DOI
- 10.1016/j.xops.2026.101323
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:53:57.611Z
- SHA-256 of the archived text
f62a8980c97d70e898b86d8c94e8d3acb290b5632b1aceb52c6e7d827128d4c2- Stable URL of this page
https://metraipolis.com/documento/dc_35d706db8108
How to cite
Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa — Europe PMC PMID:42602510 — Europe PMC (en), https://europepmc.org/article/MED/42602510 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35d706db8108 (Metraipolis archive dc_35d706db8108, sha256 f62a8980c97d70e898b86d8c94e8d3acb290b5632b1aceb52c6e7d827128d4c2)
BibTeX
@misc{dc35d706db8108,
title = {Phase I/IIa Study of an Intravitreal Optogenetic Therapy (AGN-151597) in Patients with Advanced Retinitis Pigmentosa — Europe PMC PMID:42602510},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42602510},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35d706db8108; sha256 f62a8980c97d70e898b86d8c94e8d3acb290b5632b1aceb52c6e7d827128d4c2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602510. Agents can read the archived copy with the MCP tool read_document.